Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+69.6%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
+69.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025986.07%
2024-85.78%
202341.36%
2022202.12%
202178.87%
2020-23.97%
2019-121.31%
2018-72.64%
20170.00%